We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Urinalysis Market: Growth, Size, Share, and Trends

Report Code MD 3259
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029

Overview

The urinalysis market, which was worth USD 4.30 billion in 2024, is expected to grow to USD 6.81 billion by 2029 at a CAGR of 9.6%. This is due to various factors, such as the increasing prevalence of urinary tract infections (UTIs), which raises demand for precise diagnostics. Increasing liver and kidney diseases are also among the contributory factors since urinalysis plays an important role in the early detection of these diseases. Moreover, the increasing geriatric population, who are more vulnerable to urinary and kidney disease, further enhances the demand. In addition to this, the increased adoption of point-of-care (POC) products is also driving market growth.

Urinalysis Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Urinalysis Market

ASIA PACIFIC:

The Asia Pacific market is expected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and high prevalence of chronic diseases.

The growth of this market is driven by the increasing burden of urinary tract infections (UTIs), diabetes, and kidney & liver diseases and the increasing adoption of PoC urine diagnostic tests.

The trend toward point-of-care testing is contributing to the growth of automated urinalysis solutions.

Emerging markets are expected to offer lucrative growth opportunities for players in the urinalysis market.

Agreements and acquisitions were the most widely adopted growth strategies by market players.

Global Urinalysis Market Dynamics

DRIVER: Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer

The increasing incidence of urinary tract infections (UTIs), diabetes, liver & kidney disease, and bladder cancer is fueling the growth of the urinalysis market. As the diseases increases, the need for early diagnosis and ongoing monitoring continues to rise. Urinalysis is essential for the early detection of disease. Additionally, increased rates of chronic illnesses, like diabetes, that lead to kidney injury also trigger the need for urinalysis. Advances in urinalysis technology, e.g., point-of-care testing and automation, are improving diagnostic quality, speed, and convenience, thus driving market growth in both clinical and home care environments.

RESTRAINT: High capital investments and lack of skilled laboratory technicians

An increase in the aging population is expected to cause a greater need to diagnose medical conditions, such as cancer or type 2 diabetes, through laboratory procedures.] At present, there is a significant shortage of laboratory technicians in both developed and developing nations. This is mainly attributed to the increasing patient population base, the retirement of elderly technicians, and the increasing number of cash-strapped colleges closing their clinical lab programs. Stringent requirements for licensure in many countries to practice as a clinical laboratory technologist discourage people from this profession. Thus, a gap between the supply and demand of pathologists and lab technicians worldwide restrains the market growth.

OPPORTUNITY: Technological advancements in urine analyzers

Urinalysis has undergone significant technological advancements in the past few decades. Visual analysis of test strips for early screening was initially replaced by manual strip readers, providing a better analysis of test results. With the increasing workload, automated analyzers were developed for biochemical analysis. Such systems minimize operator interference in performing tests. For example, in March 2023, Analyticon Biotechnologies GmbH (Germany), introduced Urilyzer Auto, which marks the advancement of automating and enhancing the precision of urine testing. Through the integration of cutting-edge methods, these systems optimize the accuracy of test results, minimize human mistakes, and expedite the process of analysis.

Sediment analysis is conducted via manual microscopy worldwide, particularly in developing economies. However, with a higher patient count, it is difficult to perform manual sediment analysis for all patient samples. Thus, automated sediment analyzers that utilize digital microscopy or flow cytometry to identify the different infectious agents and other casts and crystals in urine samples entered the market. These devices also help standardize sediment analysis. Urinary flow cytometry is an alternative to automated microscopy, and a more thorough analysis of flow cytometric data has enabled rapid differentiation of urinary microorganisms.

By introducing laboratory-on-a-chip approaches and microfluidics, new affordable applications for quantitative urinalysis and readout on cell phones may become available in the coming years.

CHALLENGE: Changing regulatory landscape

Regulatory and legal requirements for in vitro diagnostics (IVD) (including urinalysis) in the US and European countries are becoming more stringent. In the US, IVD products are defined under 21 CFR 809 and regulated under guidelines similar to medical devices. The FDA released new FDA guidance documents. Under US federal regulations, device manufacturers must submit a 510(k) application for further modifications to a device. New applications may be required for software updates, new software installation in an existing device, or any other changes made to these devices.

Global Urinalysis Market Ecosystem Analysis

The urinalysis market functions within a dynamic ecosystem that encompasses multiple types of products such as consumables and instruments. The end user comprise diagnostic labs, hospitals & clinics, home care settings, and research laboratories & institutes. Companies make an effort to optimize the devices for accuracy and precision while distributors are third-party vendors and e-commerce websites that make accessibility easier. All these factors contribute to the development and expansion of the urinalysis market.

Urinalysis Market Ecosystem

The largest share in the urinalysis market in 2023 was held by the consumables segment, by product.

Segmented by different product, the urinalysis market consists of consumables and instruments. The largest share of the market in 2023 was held by the consumables segment. Consumables like reagent strips, quality control solutions, and sample collection cups are fundamental to urinalysis, delivering the materials for effective and precise test results. Since each test calls for fresh supplies, their repeated nature provides sustained demand. The rising incidence of urinalysis, prompted by the expanding geriatric population and the prevalence of chronic illnesses, also drives the demand for consumables.

Disease screening segment dominated the urinalysis market in 2023, based on application.

On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility testing. The disease screening segment accounted for the largest share of the urinalysis market in 2023. Urinalysis plays a crucial role in the early detection and monitoring of various conditions such as diabetes, kidney disease, urinary tract infections, and liver disease. With an increasing global focus on preventive healthcare and early intervention, healthcare providers are prioritizing routine screenings to identify diseases at an earlier, more treatable stage. This trend is particularly significant given the aging population, which is more susceptible to chronic conditions requiring regular monitoring. The widespread adoption of urinalysis in disease screening programs, along with advancements in testing technologies that enhance accuracy and ease of use, underscores its dominance in the market. Moreover, the rising government healthcare initiatives promoting routine screening contributes to its market dominance. The increased emphasis on proactive management of health and early detection of disease has propelled the extensive use of urinalysis as primary tool in disease screening, also propelling market growth.

North America accounted for the largest share of the urinalysis market in 2023.

Categorized into six primary regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries, the urinalysis market witnessed North America taking the forefront in 2023. North America, particularly the US and Canada, boasts advanced healthcare systems with well-established infrastructure for early disease diagnosis. This infrastructure supports the adoption of innovative technologies like advanced urine analyzers. The region dominance is also supported by high healthcare expenditure, high emphasis on preventive treatment, and rising aging population, all of which boost the demand for diagnostic tool like urinalysis. Additionally, high level of healthcare awareness and government efforts towards enhanced detection and control of diseases further augment the market.

LARGEST SHARE IN 2023
US LARGEST MARKET IN THE REGION
Urinalysis Market

Recent Developments of Urinalysis Market

  • In February 2024, Sysmex Corporation (Japan) established direct sales and service activities in Italy across various field such as urinalysis. The corporation wanted to expand its presence in Italy by improving its market share and resolving many challenges in the medical environment by communicating directly with customers.
  • In November 2023, Siemens Healthineers AG (Germany) introduced the Atellica UAS 60 Analyzer, a urine sediment analysis solution. The new instrument automates a laboratory's urinalysis process, providing complete field-of-view digital imaging that closely replicates manual microscopy.
  • In July 2023, Siemens Healthineers (Germany) opened an Innovation Center in Erlangen, Germany, which focuses on the open innovation concept for collaborations with clinical and academic partners, as well as other companies and startups.
  • In April 2023, Cardinal Health Inc. (US) announced the opening of two new distribution centers in Central Ohio, which will support its Medical segment, focusing on its US Medical Products and Distribution (USMPD) and At-home Solutions businesses.
  • In February 2023, Siemens Healthineers (Germany) and Unilabs (Switzerland) announced a multi-year agreement. Under this agreement, Unilabs will modernize its healthcare infrastructure across its network to improve customer service and quality, thereby improving patient health. Siemens Healthineers’ solutions will enhance Unilabs’ laboratory operations, throughput, and clinical equivalence across its testing network.
  • In September 2022, Sysmex Corporation (Japan) launched the UF-1500 Fully Automated Urine Particle Analyzer (UF-1500) for use in urine sediment testing.

Key Market Players

Want to explore hidden markets that can drive new revenue in Urinalysis Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $4.3 billion
Projected Revenue by 2029 $6.8 billion
Revenue Rate Poised to Grow at a CAGR of 9.6%
Market Driver Rising geriatric population and subsequent increase in age-associated diseases
Market Opportunity Technological advancements in urine analyzers

 

 

Key Questions Addressed by the Report

What are the recent trends affecting the urinalysis market?
Recent trends affecting the urinalysis market are the increasing burden of chronic diseases, exploration of poc tests, the development of new and improved reagent strips and sensors, and tevhnological advancements in analyzers
What are the major types of urinalysis products?
The urinalysis market is broadly segmented into consumables and instruments. The consumables segment took the lead in the urinalysis market in 2023. Consumables are the dominant segment of the urinalysis market because they are a fundamental component of all tests since they contain reagents, controls, and test strips that are used in routine urinalysis tests. The frequent use of urinalysis tests in all healthcare facilities, such as hospitals, clinics, and diagnostic laboratories, generates sustained demand for these consumables.
Who are the key players in the urinalysis market?
The key players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health Inc. (US), Abbott (US), Danaher Corporation (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics Holdings plc (UK), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Co., Ltd. (China), DIRUI INDUSTRIAL CO., LTD. (China), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).
What are the major applications of urinalysis?
The urinalysis market is bifurcated into disease sreening and pregnancy & fertility testing. The disease screening segment held the largest portion of the urinalysis market in 2023. Urinalysis is a non-invasive, cost-effective, and efficient diagnostic tool that helps identify diseases such as diabetes, kidney disorders, liver diseases, and urinary tract infections at an early stage. The growing prevalence of these chronic conditions, particularly among the aging population, necessitates regular screening and monitoring. Moreover, routine urinalysis is a standard component of preventive healthcare check-ups and is widely used in clinical settings for general health assessments. The simplicity and accessibility of urinalysis make it a preferred choice for large-scale screening programs, contributing to its dominant share in the market. Advances in urinalysis technology, including automated analyzers and improved reagent strips, have further enhanced the accuracy and convenience of disease screening, reinforcing its leading position in the urinalysis market.
Which region is lucrative for the urinalysis market?
The Asia Pacific region, comprising economies like China and India, presents promising market opportunities for the urinalysis market. Furthermore, the Asia Pacific region is witnessing high investments in healthcare and development of infrastructure, raising access to diagnostic equipment such as urinalysis. The growing incidence of chronic conditions such as diabetes and kidney disease and the increasing population of elderly are also propelling demand for ongoing monitoring and early detection. Also, growing health consciousness and widening healthcare services availability throughout the region are driving the urinalysis market in Asia Pacific at a fast pace.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
35
RESEARCH METHODOLOGY
39
EXECUTIVE SUMMARY
51
PREMIUM INSIGHTS
55
MARKET OVERVIEW
58
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
    - Rising geriatric population and subsequent increase in age-associated diseases
    - Increasing adoption of PoC urine diagnostic tests
    RESTRAINTS
    - Availability of refurbished urine analyzers
    - High capital investments and lack of skilled laboratory technicians
    OPPORTUNITIES
    - Growth opportunities in emerging countries
    - Technological advancements in urine analyzers
    - Increasing government initiatives and funding for preventive care
    CHALLENGES
    - Changing regulatory landscape
  • 5.3 PRICING ANALYSIS
    INDICATIVE PRICE TREND, BY PRODUCT, 2021—2024
    INDICATIVE PRICE TREND OF URINALYSIS PRODUCTS, BY REGION, 2021—2024
  • 5.4 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    IMPORT DATA (HS CODE 3822), 2019—2023
    EXPORT DATA (HS CODE 3822), 2019—2023
  • 5.8 ECOSYSTEM ANALYSIS
    URINALYSIS MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Automated urine analyzers
    COMPLEMENTARY TECHNOLOGIES
    - Point-of-care urine analyzers
    ADJACENT TECHNOLOGIES
    - Multiplex PCR
  • 5.13 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
    EVALUATION OF AUTOMATED URINE ANALYZERS
  • 5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET
    KEY USE CASES
    FUTURE OF AI/GEN AI
URINALYSIS MARKET, BY PRODUCT
97
  • 6.1 INTRODUCTION
    PRIMARY NOTES
    - Key industry insights
  • 6.2 CONSUMABLES
    PREGNANCY & FERTILITY KITS
    - Rapid accessibility and testing convenience to drive market
    DIPSTICKS
    - Low cost to increase adoption
    REAGENTS
    - Increasing use of controls and calibrators to drive market
    DISPOSABLES
    - Wise usage in hospitals and clinical laboratories to support market growth
  • 6.3 INSTRUMENTS
    AUTOMATED URINE ANALYZERS
    - Integrated urine analyzers
    - Sediment urine analyzers
    - Biochemical urine analyzers
    SEMI-AUTOMATED URINE ANALYZERS
    - Extensive use in hospitals & clinics to drive segment growth
    POINT-OF-CARE URINE ANALYZERS
    - Need for rapid testing to drive demand for PoC urine analyzers
URINALYSIS MARKET, BY TEST TYPE
134
  • 7.1 INTRODUCTION
    PRIMARY NOTES
    - Key industry insights
  • 7.2 PREGNANCY & FERTILITY TESTS
    RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET
  • 7.3 BIOCHEMICAL TESTS
    LABORATORY TESTS
    - Growing incidence of UTIs and other kidney diseases to drive market
    POC TESTS
    - Convenience of PoC testing to drive segment growth
  • 7.4 SEDIMENT URINALYSIS
    INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET
URINALYSIS MARKET, BY APPLICATION
150
  • 8.1 INTRODUCTION
    PRIMARY NOTES
    - Key industry insights
  • 8.2 DISEASE SCREENING
    URINARY TRACT INFECTIONS
    - Increasing prevalence of UTIs to drive segment growth
    KIDNEY DISEASES
    - Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth
    DIABETES
    - Development of advanced analytical tools to drive market
    LIVER DISEASES
    - High prevalence of liver diseases to support market growth
    OTHER DISEASE SCREENING APPLICATIONS
  • 8.3 PREGNANCY & FERTILITY TESTING
    NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
URINALYSIS MARKET, BY END USER
170
  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTIC LABORATORIES
    INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
  • 9.3 HOSPITALS & CLINICS
    GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH
  • 9.4 HOME CARE SETTINGS
    INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
  • 9.5 RESEARCH LABORATORIES & INSTITUTES
    DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
URINALYSIS MARKET, BY REGION
182
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Rising prevalence of chronic diseases to drive market
    CANADA
    - Rising burden of CKD to augment market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing healthcare expenditure to fuel market growth
    UK
    - Rising government healthcare expenditure to propel market
    FRANCE
    - High R&D expenditure to provide growth opportunities
    ITALY
    - Rising prevalence of diabetes to drive market
    SPAIN
    - Growing elderly population to propel market
    RUSSIA
    - Long-term healthcare investment initiatives by government to support market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Improving healthcare infrastructure to support market growth
    JAPAN
    - Favorable regulatory framework to drive market growth
    INDIA
    - Increasing investments in healthcare system to drive market
    AUSTRALIA
    - Rising prevalence of chronic diseases to propel market
    SOUTH KOREA
    - Growing medical tourism to drive demand for urinalysis
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Largest healthcare market in Latin America
    MEXICO
    - Popularity in medical tourism to drive market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    UNFAVORABLE REIMBURSEMENT POLICIES TO RESTRAIN MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    RISING HEALTHCARE EXPENDITURE AND SUPPORTIVE GOVERNMENT INITIATIVES TO PROPEL MARKET
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
287
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN URINALYSIS MARKET
  • 11.3 REVENUE ANALYSIS, 2021—2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Application footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPANY FOOTPRINT: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of startups/SMEs, by product and application
    - Competitive benchmarking of startups/SMEs, by region
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
305
  • 12.1 KEY PLAYERS
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD
    - Business overview
    - Products offered
    - MnM view
    CARDINAL HEALTH, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - MnM view
    SYSMEX CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    QUIDELORTHO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products offered
    EKF DIAGNOSTICS HOLDINGS PLC
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    ARKRAY, INC.
    ACON LABORATORIES, INC.
    77 ELEKTRONIKA KFT.
    URIT MEDICAL ELECTRONIC CO., LTD.
    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    DIRUI INDUSTRIAL CO., LTD.
    BIOBASE GROUP
    ERBA MANNHEIM
    ALPHATEC SCIENTIFIC E.I.R.L.
    TECO DIAGNOSTICS
    ANALYTICON BIOTECHNOLOGIES GMBH
    BIOWAY BIOLOGICAL TECHNOLOGY CO., LTD
    HIGH TECHNOLOGY, INC.
    AGAPPE DIAGNOSTICS LTD
    TOYOBO CO., LTD.
    DIALAB GMBH
    QUANTIMETRIX
    BIOCARE CORPORATION
    RANDOX LABORATORIES LTD.
    PZ CORMAY S.A.
    YD DIAGNOSTICS
    CONTEC MEDICAL SYSTEMS CO., LTD.
    BIOPANDA REAGENTS LTD.
    CLARITY DIAGNOSTICS, LLC
    GENUINE BIOSYSTEM PVT LTD.
APPENDIX
363
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 URINALYSIS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 URINALYSIS MARKET: RISK ASSESSMENT
  • TABLE 3 ESTIMATED NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
  • TABLE 4 GLOBAL BLADDER CANCER, 2022
  • TABLE 5 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050
  • TABLE 6 INDICATIVE PRICE TREND OF URINALYSIS PRODUCTS, 2021—2024 (USD)
  • TABLE 7 INDICATIVE PRICE OF URINALYSIS PRODUCTS, BY REGION, 2021—2024 (USD)
  • TABLE 8 URINALYSIS MARKET: LIST OF MAJOR PATENTS, 2022–2025
  • TABLE 9 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS (HS CODE 3822), BY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 10 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS (HS CODE 3822), BY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 11 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%)
  • TABLE 13 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
  • TABLE 14 EUROPE: CLASSIFICATION OF DEVICES
  • TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 16 AUSTRALIA: CLASSIFICATION OF IVD MEDICAL DEVICES
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 23 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 24 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET
  • TABLE 25 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 26 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET
  • TABLE 32 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET
  • TABLE 38 DIPSTICKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET
  • TABLE 44 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET
  • TABLE 55 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 56 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY,2022–2029 (USD MILLION)
  • TABLE 61 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET
  • TABLE 62 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 63 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET
  • TABLE 69 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET
  • TABLE 75 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY,2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET
  • TABLE 92 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET
  • TABLE 98 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET
  • TABLE 104 POC URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET
  • TABLE 111 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET
  • TABLE 117 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 KEY PRODUCTS IN LABORATORY TESTS MARKET
  • TABLE 124 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 KEY PRODUCTS IN POC TESTS MARKET
  • TABLE 130 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET
  • TABLE 136 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 142 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%)
  • TABLE 154 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
  • TABLE 160 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20–79 YEARS (USD BILLION)
  • TABLE 161 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 182 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 198 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 URINALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: MACROECONOMIC INDICATORS FOR URINALYSIS MARKET
  • TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 215 US: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 216 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 US: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 US: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 223 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 US: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 225 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 226 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 233 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 CANADA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 235 EUROPE: MACROECONOMIC INDICATORS FOR URINALYSIS MARKET
  • TABLE 236 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 238 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 245 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 247 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 248 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 255 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 GERMANY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 257 UK: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 258 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 UK: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 UK: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 265 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 UK: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 267 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 268 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 275 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 FRANCE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 277 ITALY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 278 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 ITALY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 285 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 ITALY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 287 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 288 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 295 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 SPAIN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 297 RUSSIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 298 RUSSIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 RUSSIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 RUSSIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 RUSSIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 RUSSIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 RUSSIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 RUSSIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 305 RUSSIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 RUSSIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 307 DEATHS DUE TO KIDNEY DISEASES PER 100,000 POPULATION, BY COUNTRY, 2020
  • TABLE 308 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 309 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 316 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: MACROECONOMIC INDICATORS FOR URINALYSIS MARKET
  • TABLE 319 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 330 CHINA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 331 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 CHINA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 338 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 CHINA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 340 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 341 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 344 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 348 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 JAPAN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 350 INDIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 351 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 INDIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 358 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 INDIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 360 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 361 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 366 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 368 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 370 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 371 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 374 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 375 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 378 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 380 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 388 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 390 LATIN AMERICA: MACROECONOMIC INDICATORS FOR URINALYSIS MARKET
  • TABLE 391 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 392 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 393 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 402 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 403 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 406 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 410 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 BRAZIL: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 412 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 413 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 420 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 MEXICO: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 422 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 423 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 424 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 430 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 432 MIDDLE EAST & AFRICA: MACROINDICATORS FOR URINALYSIS MARKET
  • TABLE 433 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 434 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 439 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 440 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 441 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 443 GCC COUNTRIES: MACROECONOMIC INDICATORS FOR URINALYSIS MARKET
  • TABLE 444 GCC COUNTRIES: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 445 GCC COUNTRIES: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 GCC COUNTRIES: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 GCC COUNTRIES: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 GCC COUNTRIES: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 GCC COUNTRIES: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 GCC COUNTRIES: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 452 GCC COUNTRIES: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 GCC COUNTRIES: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 454 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2021– FEBRUARY 2025
  • TABLE 455 URINALYSIS MARKET: DEGREE OF COMPETITION
  • TABLE 456 URINALYSIS MARKET: REGION FOOTPRINT
  • TABLE 457 URINALYSIS MARKET: PRODUCT FOOTPRINT
  • TABLE 458 URINALYSIS MARKET: APPLICATION FOOTPRINT
  • TABLE 459 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 460 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT AND APPLICATION
  • TABLE 461 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 462 URINALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025
  • TABLE 463 URINALYSIS MARKET: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 464 URINALYSIS MARKET: EXPANSIONS, JANUARY 2021–FEBRUARY 2025
  • TABLE 465 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 466 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
  • TABLE 467 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2025
  • TABLE 468 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 469 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– FEBRUARY 2025
  • TABLE 470 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
  • TABLE 471 F. HOFFMAN-LA ROCHE LTD: PRODUCTS OFFERED
  • TABLE 472 CARDINAL HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 473 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
  • TABLE 474 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2021–FEBRUARY 2025
  • TABLE 475 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 476 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 477 DANAHER CORPORATION: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 478 DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021– FEBRUARY 2025
  • TABLE 479 ABBOTT: COMPANY OVERVIEW
  • TABLE 480 ABBOTT: PRODUCTS OFFERED
  • TABLE 481 SYSMEX CORPORATION: COMPANY OVERVIEW
  • TABLE 482 SYSMEX CORPORATION: PRODUCTS OFFERED
  • TABLE 483 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 484 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021–FEBRUARY 2025
  • TABLE 485 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 486 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 487 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–FEBRUARY 2024
  • TABLE 488 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 489 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 490 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–FEBRUARY 2025
  • TABLE 491 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021– FEBRUARY 2025
  • TABLE 492 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 493 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 494 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 495 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 496 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
  • TABLE 497 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS OFFERED
  • TABLE 498 EKF DIAGNOSTICS HOLDINGS PLC: DEALS, JANUARY 2021–FEBRUARY 2025
LIST OF FIGURES
 
  • FIGURE 1 URINALYSIS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 URINALYSIS MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 URINALYSIS MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 10 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
  • FIGURE 16 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET
  • FIGURE 17 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET
  • FIGURE 18 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 19 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 20 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014–DECEMBER 2024)
  • FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 24 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 25 URINALYSIS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS
  • FIGURE 28 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS
  • FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 30 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 31 MARKET POTENTIAL OF AI IN ENHANCING URINALYSIS MARKET
  • FIGURE 32 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
  • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2021–2023 (USD MILLION)
  • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET (2023)
  • FIGURE 36 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 URINALYSIS MARKET: COMPANY FOOTPRINT
  • FIGURE 38 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 BRAND/PRODUCT COMPARISON: URINE ANALYZERS
  • FIGURE 42 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 43 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2024)
  • FIGURE 44 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 47 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 49 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
  • FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)

 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the urinalysis market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Urinalysis  Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

F. Hoffmann-La Roche Ltd

Sales Manager

Abbott

Sales Executive

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the urinalysis market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the urinalysis market have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

The research methodology used to estimate the market size includes the following:

Urinalysis  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and manages various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical & sediment analysis. In this report, we have also discussed pregnancy & fertility tests for urine analysis.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the urinalysis market, by product, test type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and GCC countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as acquisitions, collaborations, partnerships, agreements, and product launches in the urinalysis market
  • To benchmark players within the urinalysis market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Available Customizations

MarketsandMarkets offers the following customizations for this market report.

Country Information

  • Additional country-level analysis of the urinalysis market

Company profiles

  • Additional five company profiles of players operating in the urinalysis market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market

Previous Versions of this Report

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027

Report Code MD 3259
Published in Feb, 2023, By MarketsandMarkets™

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type - Global Forecast to 2026

Report Code MD 3259
Published in Aug, 2021, By MarketsandMarkets™

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024

Report Code MD 3259
Published in Mar, 2019, By MarketsandMarkets™

Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021

Report Code MD 3259
Published in Jul, 2016, By MarketsandMarkets™

Urinalysis Market by Product (Dipstick, Reagent, Urine Analyzer, POC), Test Type (Biochemical, Sediment, Microscopic), Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy), End User (Hospital, Research Institute, Home) - Forecast to 2019

Report Code MD 3259
Published in Mar, 2015, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Urinalysis Market

MnM Analyst

Jul, 2023

Below are the top 3 technological advancements in urinalysis market:
1. Automated Urine Analyzers: Automated urine analyzers are sophisticated machines that can rapidly and accurately analyze a urine sample. This technology allows for automated testing of multiple parameters in a single sample, eliminating the need for manual handling and improving the accuracy of results.
2. High-throughput Urine Testing: High-throughput urine testing technology uses robotic and automated systems to process a large number of urine samples at once, significantly reducing the time and cost of performing urinalysis.
3. Point-of-Care Urine Testing: Point-of-care urine testing technology allows for testing to be done quickly and easily in a clinical setting, without the need for a laboratory. This technology is particularly useful for rapid screening and diagnosis of urinary tract infections..

Jane

Jul, 2023

what is the technological advancement in urinalysis market?.

DMCA.com Protection Status